![[ICO]](/icons/blank.gif){kind=icon}
![[PARENTDIR]](/icons/back.gif){kind=icon}
![[ ]](/icons/layout.gif){kind=icon}
![[ ]](/icons/unknown.gif){kind=icon}
| Name | Last modified | Size | Description |
|---|---|---|---|---|
| Parent Directory | - | ||
| 1753881613_Edital com TR PE9043025 RP Medicamentos Grupo II.pdf | 2025-07-30 10:20 | 1.9M | |
| 1753881616_RelacaoItens98600105904302025000.pdf | 2025-07-30 10:20 | 90K | |
| 1754312984_ESPELHO DROGAFONTE PE 90430.xls | 2025-08-04 10:09 | 760K | |
| 1754312986_ESPELHO DROGAFONTE PE 90430.pdf | 2025-08-04 10:09 | 70K | |
| 1754423577_HABILITACAO VAL 12.08.rar | 2025-08-05 16:52 | 60M | |
| 1754487909_COPIA CMED ID 11255.rar | 2025-08-06 10:45 | 7.0M | |
| 1754933596_LANCE 11255.pdf | 2025-08-11 14:33 | 1.3M | |
| 1755873252_DOCS ATUALIZADOS.rar | 2025-08-22 11:34 | 2.0M | |
| 1755873725_904302025986001proposta.pdf | 2025-08-22 11:42 | 130K | |
| 1755874006_BULA 32.pdf | 2025-08-22 11:46 | 1.0M | |
| 1755874016_REG 32.pdf | 2025-08-22 11:46 | 93K | |
| 1758726987_ARP 160.2025.pdf | 2025-09-24 12:16 | 354K | |
| 1759261101_ARP 90430.2025.pdf | 2025-09-30 16:38 | 354K | |
| 1760985021_EXTRATO DA ATA N16025 PE9043025 RP Medicamentos Grupo II D.O.pdf | 2025-10-20 15:30 | 1.1M | |
| 1760985039_ATA N1602025 PE9043025 RP Medicamentos Grupo II FINALIZADA.pdf | 2025-10-20 15:30 | 633K | |